Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McInnes

Showing results (191-200 of 537) with videos related to

Pageof 54
Sort By:
Rheumatology (Oxford, England)|August 14, 2018
Expression of interleukin-18 in muscle tissue of patients with polymyositis or dermatomyositis and effects of conventional immunosuppressive treatmentSevim Barbasso Helmers, Mei Bruton, Ingela Loell, et al.
Lancet (London, England)|June 23, 2004
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trialDavid W McCarey, Iain B McInnes, Rajan Madhok, et al.
European Journal of Immunology|September 18, 2007
IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cellsWanda Niedbala, Xiao-Qing Wei, Beilei Cai, et al.
Plos One|August 22, 2014
Identification of urinary peptide biomarkers associated with rheumatoid arthritisAngelique Stalmach, Hanna Johnsson, Iain B McInnes, et al.
The American Journal of Pathology|February 23, 2008
Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profilesM Cristina Lebre, Sarah L Jongbloed, Sander W Tas, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 30, 2004
Abnormal first trimester serum interleukin 18 levels are associated with a poor outcome in women with a history of recurrent miscarriageRhoda Wilson, Judith Moor, Carol Jenkins, et al.
Rheumatology and Therapy|January 23, 2026
Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS StudyLaure Gossec, Xenofon Baraliakos, James Galloway, et al.
Annals of the Rheumatic Diseases|March 11, 2021
TNF is a homoeostatic regulator of distinct epigenetically primed human osteoclast precursorsCecilia Ansalone, John Cole, Sabarinadh Chilaka, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2001
A proinflammatory role of IL-18 in the development of spontaneous autoimmune diseaseE Esfandiari, I B McInnes, G Lindop, et al.
Rheumatology (Oxford, England)|September 19, 2025
Impact of dactylitis and enthesitis resolution on disease control in guselkumab-treated PsA patients with TNFi-IR: COSMOS post-hoc analysisHelena Marzo-Ortega, Iain B McInnes, Mohamed Sharaf, et al.
Pageof 54

Showing results (191-200 of 537) with videos related to

Sort By:
Pageof 54
Rheumatology (Oxford, England)|August 14, 2018
Expression of interleukin-18 in muscle tissue of patients with polymyositis or dermatomyositis and effects of conventional immunosuppressive treatmentSevim Barbasso Helmers, Mei Bruton, Ingela Loell, et al.
Lancet (London, England)|June 23, 2004
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trialDavid W McCarey, Iain B McInnes, Rajan Madhok, et al.
European Journal of Immunology|September 18, 2007
IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cellsWanda Niedbala, Xiao-Qing Wei, Beilei Cai, et al.
Plos One|August 22, 2014
Identification of urinary peptide biomarkers associated with rheumatoid arthritisAngelique Stalmach, Hanna Johnsson, Iain B McInnes, et al.
The American Journal of Pathology|February 23, 2008
Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profilesM Cristina Lebre, Sarah L Jongbloed, Sander W Tas, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 30, 2004
Abnormal first trimester serum interleukin 18 levels are associated with a poor outcome in women with a history of recurrent miscarriageRhoda Wilson, Judith Moor, Carol Jenkins, et al.
Rheumatology and Therapy|January 23, 2026
Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS StudyLaure Gossec, Xenofon Baraliakos, James Galloway, et al.
Annals of the Rheumatic Diseases|March 11, 2021
TNF is a homoeostatic regulator of distinct epigenetically primed human osteoclast precursorsCecilia Ansalone, John Cole, Sabarinadh Chilaka, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2001
A proinflammatory role of IL-18 in the development of spontaneous autoimmune diseaseE Esfandiari, I B McInnes, G Lindop, et al.
Rheumatology (Oxford, England)|September 19, 2025
Impact of dactylitis and enthesitis resolution on disease control in guselkumab-treated PsA patients with TNFi-IR: COSMOS post-hoc analysisHelena Marzo-Ortega, Iain B McInnes, Mohamed Sharaf, et al.
Pageof 54